Matthew L Grove. Show Affiliations »
Abstract
Mesh： See more » Cardiovascular Diseases/chemically inducedChemical and Drug Induced Liver InjuryCyclooxygenase 2Drug ApprovalHumansIsoenzymes/adverse effectsIsoxazoles/adverse effectsLeflunomideMembrane ProteinsProstaglandin-Endoperoxide Synthases/adverse effectsRecordsUnited KingdomUnited StatesUnited States Food and Drug Administration
Substances： See more » IsoenzymesIsoxazolesMembrane ProteinsCyclooxygenase 2PTGS2 protein, humanProstaglandin-Endoperoxide SynthasesLeflunomide
Year: 2002 PMID： 12364314 PMCID： PMC1124285 DOI： 10.1136/bmj.325.7367.776
Source DB: PubMed Journal: BMJ ISSN： 0959-8138